GlassScriptPhysician profile
Latasha L Cunningham
NPI 1710118161
$1,605.57
in general payments reported to CMS, 2019-2025
7 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $502 · 2023: $743 · 2024: $247 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,103.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $932.21 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $379.67 | 2022-2024 | Mounjaro, Trulicity, Jardiance |
| Rhythm Pharmaceuticals, INC. | $161.78 | 2022-2023 | Imcivree |
| Currax Pharmaceuticals LLC | $44.57 | 2022-2024 | Contrave |
| Tactile Systems Technology INC | $40.35 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $28.47 | 2022-2023 | Farxiga |
| Edwards Lifesciences Corporation | $18.52 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Latasha Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.